Anne Demols

Summary

Country: Belgium

Publications

  1. ncbi request reprint Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis
    Anne Demols
    Department of Gastroenterology, Hôpital Erasme and Laboratory of Experimental Gastroenterology, Universite Libre de Bruxelles, B 1070 Brussels, Belgium
    Am J Physiol Gastrointest Liver Physiol 282:G1105-12. 2002
  2. ncbi request reprint Adjuvant therapy in gastric and cardia cancer: should we irradiate?
    Jean Luc Van Laethem
    Department of Gastroenterology, Gastrointestinal Oncology Unit, Erasme University Hospital, ULB Brussels, Brussels, Belgium
    Curr Opin Oncol 18:381-5. 2006
  3. ncbi request reprint The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment
    Anne Demols
    Department of Gastroenterology, GI Cancer Unit, Erasme University Hospital, Universite Libre de Bruxelles, Route de Lennik, 808, 1070 Brussels, Belgium
    Best Pract Res Clin Gastroenterol 21:1015-29. 2007
  4. pmc Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
    A Demols
    1Department of Gastroenterology, GI Oncology Unit, Erasme University Hospital, Route de Lennik 808, Brussels 1070, Belgium
    Br J Cancer 94:481-5. 2006
  5. ncbi request reprint Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study
    Anne Demols
    Medico Surgical Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 62:1351-6. 2005
  6. ncbi request reprint Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study
    Jean Luc Van Laethem
    Medico Surgical Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 56:974-80. 2003
  7. doi request reprint Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Raphael Marechal
    Gastroenterology Department, Gastrointestinal Cancer Unit, Erasme Hospital University, Brussels, Belgium
    Pancreas 36:e16-21. 2008
  8. doi request reprint Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer
    Raphael Marechal
    Department of Gastroenterology, GI Cancer Unit, Erasme University Hospital, Universite Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium
    Drugs Aging 30:155-65. 2013
  9. ncbi request reprint Adjuvant chemotherapy for colorectal cancer
    Anne Demols
    Department of Gastroenterology, Erasme University Hospital, Route de Lennik, 808, 1070 Brussels, Belgium
    Curr Gastroenterol Rep 4:420-6. 2002
  10. ncbi request reprint New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines
    Anne Demols
    Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium
    JOP 4:49-57. 2003

Detail Information

Publications10

  1. ncbi request reprint Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis
    Anne Demols
    Department of Gastroenterology, Hôpital Erasme and Laboratory of Experimental Gastroenterology, Universite Libre de Bruxelles, B 1070 Brussels, Belgium
    Am J Physiol Gastrointest Liver Physiol 282:G1105-12. 2002
    ..Endogenous IL-10 controls the regeneration phase and limits the severity of fibrosis and glandular atrophy induced by repeated episodes of acute pancreatitis in mice...
  2. ncbi request reprint Adjuvant therapy in gastric and cardia cancer: should we irradiate?
    Jean Luc Van Laethem
    Department of Gastroenterology, Gastrointestinal Oncology Unit, Erasme University Hospital, ULB Brussels, Brussels, Belgium
    Curr Opin Oncol 18:381-5. 2006
    ..The purpose of this review is to comment on the current status and the place of the (neo)adjuvant therapy of gastric cancer, and on the standardization of care in this setting...
  3. ncbi request reprint The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment
    Anne Demols
    Department of Gastroenterology, GI Cancer Unit, Erasme University Hospital, Universite Libre de Bruxelles, Route de Lennik, 808, 1070 Brussels, Belgium
    Best Pract Res Clin Gastroenterol 21:1015-29. 2007
    ....
  4. pmc Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study
    A Demols
    1Department of Gastroenterology, GI Oncology Unit, Erasme University Hospital, Route de Lennik 808, Brussels 1070, Belgium
    Br J Cancer 94:481-5. 2006
    ..GEMOX is a well-tolerated, active regimen that may provide a benefit to patients with advanced pancreatic cancer after progression following standard gemcitabine treatment...
  5. ncbi request reprint Adjuvant gemcitabine and concurrent continuous radiation (45 Gy) for resected pancreatic head carcinoma: a multicenter Belgian Phase II study
    Anne Demols
    Medico Surgical Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 62:1351-6. 2005
    ..To evaluate the feasibility and tolerance of a postoperative course of gemcitabine (GEM) combined with continuous radiation after curative resection of pancreatic adenocarcinoma...
  6. ncbi request reprint Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study
    Jean Luc Van Laethem
    Medico Surgical Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium
    Int J Radiat Oncol Biol Phys 56:974-80. 2003
    ..We evaluated the feasibility of postoperative administration of GEM alone, followed by concurrent GEM and irradiation (RT) after curative resection for pancreatic adenocarcinoma...
  7. doi request reprint Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Raphael Marechal
    Gastroenterology Department, Gastrointestinal Cancer Unit, Erasme Hospital University, Brussels, Belgium
    Pancreas 36:e16-21. 2008
    ..Gemcitabine is the backbone therapy of patients with advanced pancreatic cancer. Its tolerability and efficacy remain poorly studied in elderly...
  8. doi request reprint Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer
    Raphael Marechal
    Department of Gastroenterology, GI Cancer Unit, Erasme University Hospital, Universite Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium
    Drugs Aging 30:155-65. 2013
    ..Gemcitabine should be preferred to 5-fluorouracil on the basis of a better risk-benefit balance...
  9. ncbi request reprint Adjuvant chemotherapy for colorectal cancer
    Anne Demols
    Department of Gastroenterology, Erasme University Hospital, Route de Lennik, 808, 1070 Brussels, Belgium
    Curr Gastroenterol Rep 4:420-6. 2002
    ..In Europe, neoadjuvant radiotherapy is recommended for stage II and III resectable rectal cancers; the role of chemotherapy remains mostly investigational...
  10. ncbi request reprint New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines
    Anne Demols
    Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium
    JOP 4:49-57. 2003
    ..The use of recombinant interleukin-10 in this indication has to be established in a multicenter prospective trial and we need to investigate the safety and efficacy of other immunomodulatory drugs and develop new specific targets...